Ficolin-2 Defends against Virulent Mycobacteria Tuberculosis Infection In Vivo, and Its Insufficiency Is Associated with Infection in Humans
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ficolin-2 Defends against Virulent Mycobacteria Tuberculosis Infection In Vivo, and Its Insufficiency Is Associated with Infection in Humans
Authors
Keywords
Mycobacterium tuberculosis, Macrophages, Tuberculosis, Mouse models, Lectins, Recombinant proteins, T cells, Enzyme-linked immunoassays
Journal
PLoS One
Volume 8, Issue 9, Pages e73859
Publisher
Public Library of Science (PLoS)
Online
2013-09-10
DOI
10.1371/journal.pone.0073859
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Residue Lys57 in the Collagen-Like Region of Human L-Ficolin and Its Counterpart Lys47 in H-Ficolin Play a Key Role in the Interaction with the Mannan-Binding Lectin-Associated Serine Proteases and the Collectin Receptor Calreticulin
- (2014) M. Lacroix et al. JOURNAL OF IMMUNOLOGY
- PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice
- (2013) Jingying Zhou et al. JOURNAL OF CLINICAL INVESTIGATION
- Early Increased Ficolin-2 Concentrations are Associated with Severity of Liver Inflammation and Efficacy of anti-Viral Therapy in Chronic Hepatitis C Patients
- (2013) Y.-L. Hu et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Interferon-γ, tumor necrosis factor, and interleukin-18 cooperate to control growth of Mycobacterium tuberculosis in human macrophages
- (2012) Cory M. Robinson et al. CYTOKINE
- Macrophage plasticity and polarization: in vivo veritas
- (2012) Antonio Sica et al. JOURNAL OF CLINICAL INVESTIGATION
- Mice Deficient in Ficolin, a Lectin Complement Pathway Recognition Molecule, Are Susceptible to Streptococcus pneumoniae Infection
- (2012) Y. Endo et al. JOURNAL OF IMMUNOLOGY
- L-Ficolin Binds to the Glycoproteins Hemagglutinin and Neuraminidase and Inhibits Influenza A Virus Infection Both in vitro and in vivo
- (2012) Qin Pan et al. Journal of Innate Immunity
- Interleukin 24 as a novel potential cytokine immunotherapy for the treatment of Mycobacterium tuberculosis infection
- (2011) Yunfeng Ma et al. MICROBES AND INFECTION
- Specifically Binding of L-ficolin to N-glycans of HCV Envelope Glycoproteins E1 and E2 Leads to Complement Activation
- (2010) Jun Liu et al. Cellular & Molecular Immunology
- Natural lysophospholipids reduce Mycobacterium tuberculosis-induced cytotoxicity and induce anti-mycobacterial activity by a phagolysosome maturation-dependent mechanism in A549 type II alveolar epithelial cells
- (2009) Emanuela Greco et al. IMMUNOLOGY
- Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil
- (2008) Jonathan E Golub et al. AIDS
- Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils
- (2008) A. Karlsson et al. GLYCOBIOLOGY
- Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens
- (2008) Meredith M. Curtis et al. IMMUNOLOGY
- Recognition of acetylated oligosaccharides by human L-ficolin
- (2008) Anders Krarup et al. IMMUNOLOGY LETTERS
- Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007
- (2008) N. Sarita Shah JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Functional SNPs in the human ficolin (FCN) genes reveal distinct geographical patterns
- (2008) Tina Hummelshøj et al. MOLECULAR IMMUNOLOGY
- Lipoarabinomannan of Mycobacterium: Mannose capping by a multifunctional terminal mannosyltransferase
- (2008) D. Kaur et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ficolins: Novel pattern recognition molecules of the innate immune response
- (2007) Valeria L. Runza et al. IMMUNOBIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started